Home : News : Local :

Photo

Top Stories

STOP-DWI Crackdown over weekend

This weekend, state and local law enforcement agencies will be …

Population drain continues for WNY

The population base of Buffalo and Niagara Falls continue to …

Marathon organizers focus on security

After the attacks at the Boston Marathon last month, security …

NYS Senate approves Jay-J's Law

The New York State Senate has passed Jay J’s law, a crackdown …

Teen learns fate for shooting boy

After being given youthful offender status, Amani Johnson …

WNY firm inks $4.6 Russian deal

Cleveland Biolabs to develop anti-infection drugs

Updated: Wednesday, 28 Nov 2012, 11:57 AM EST
Published : Wednesday, 28 Nov 2012, 11:57 AM EST

BUFFALO, NY (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.

Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.

The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.

Comments

With WIVB.com's new commenting system you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. If you have a WIVB.com login you can still use it in our Participate section.